phenyl acetate has been researched along with beraprost in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kageyama, Y; Nishio, S; Uenishi, N; Umetsu, T; Yamada, N; Yamaguchi, M | 1 |
| Chen, YL; Chern, CY; Kan, WM; Shen, HW | 1 |
| Benyahia, C; Boukais, K; Clapp, L; Danel, C; Fabre, A; Gomez, I; Leséche, G; Longrois, D; Norel, X; Silverstein, A | 1 |
3 other study(ies) available for phenyl acetate and beraprost
| Article | Year |
|---|---|
Effect of beraprost sodium (TRK-100) on acetic acid-induced skin ulcer.
Topics: Acetates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Epoprostenol; Indomethacin; Male; Platelet Aggregation Inhibitors; Rats; Rats, Inbred Strains; Skin; Skin Ulcer | 1989 |
The effect of prostacyclin agonists on the differentiation of phorbol ester treated human erythroleukemia cells.
Topics: Acetates; Cell Differentiation; Epoprostenol; Humans; Leukemia, Erythroblastic, Acute; Oxazoles; Phorbol Esters; Thrombopoiesis | 2007 |
A comparative study of PGI2 mimetics used clinically on the vasorelaxation of human pulmonary arteries and veins, role of the DP-receptor.
Topics: Acetates; Aged; Drug Evaluation, Preclinical; Epoprostenol; Female; Humans; Iloprost; In Vitro Techniques; Inhibitory Concentration 50; Male; Middle Aged; Molecular Mimicry; Pulmonary Artery; Pulmonary Veins; Pyrazines; Receptors, Epoprostenol; Receptors, Immunologic; Receptors, Prostaglandin; Receptors, Prostaglandin E, EP4 Subtype; Vasodilation; Vasodilator Agents | 2013 |